Cyclophosphamide treatment in active multiple sclerosis.

Enrique Gomez-FigueroaEfrain Gutierrez-LanzAlonso Alvarado-BolañosAdriana Casallas-VanegasChristian Garcia-EstradaIndhira Zabala-AngelesArturo Cadena-FernandezRivas-Alonso VeronicaTreviño-Frenk IreneJosé Flores-Rivera

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2021)

CYC continues to be a valid therapeutic option, especially in regions with limited access to high-efficiency therapies particularly in patients with high relapsing activity and malignant course.

Keyphrases

multiple sclerosis
high efficiency
white matter
low dose
high dose
combination therapy